MedReleaf (TSX: LEAF) Gains Approval From Health Canada To Sell Cannabis Oil Softgel Capsules

MedReleaf (TSX: LEAF), Canada’s first and only ISO 9001 and ICH-GMP certified cannabis producer, recently announced that their company has gained approval from Health Canada for the production and sale of their new cannabis oil soft gel capsules.

MedReleaf plans to sell soft gel capsules because you can monitor patient dosages more accurately. Its also familiar to patients who have never smoked cannabis before but, are interested in the potential health benefits of the plant

MedReleaf’s product formulators plan to use a color coding system so that the different varieties of soft gels are easily identified. Blue for the nighttime, Yellow for the daytime, Colorless for CBD based gel caps, and Purple for a gel cap that contains a dosage of both THC and CBD.

Cannabis Oil Softgel Capsule Dominance THC per Capsule CBD per Capsule
Avidekel Indica <2 mg 20 mg
Midnight Sativa 2 mg 3 mg
Alaska and Luminarium Sativa 5 mg 0 mg
Sedamen and Stellio Indica 5 mg 0 mg

From the press release:
“Our product development teams continue to set the standard for innovation and quality in our industry with pharmaceutical-grade softgel capsules that faithfully capture both cannabinoid and terpenes profiles of our award-winning varieties. The addition of softgel capsules to our product line will enhance our efforts to build physician support for medical cannabis and are more cost effective to produce, easier to swallow, and have a longer shelf-life than standard oil capsules,” added Neil Closner, CEO of MedReleaf.

www.medreleaf.com

Source

Related posts

Organigram Names Former ICC Labs CEO to Lead International Expansion

Editor

Grenco Science and Vapium Announce Joint Venture to Introduce Accudose, a First-of-Its-Kind, Accurate Dosing Technology for Cannabis Consumption

creativemind

Aphria Triples Production Capacity, Gains Approval for Part III Expansion

Editor

Leave a Comment

%d bloggers like this: